Zapata Quantum, Inc. is a generative artificial intelligence firm. It utilizes sophisticated data science and engineering methodologies to devise solutions applicable on an industrial scale. The company was established in 2017 by Christopher Savoie, Alan Aspuru-Guzik, Yudong Cao, Jonathan Olson, Peter Johnson, and Jonathan Romero-Fontalvo, and its headquarters are located in Boston, Massachusetts.
Zapata Quantum Joins IBM Quantum Network to Accelerate Mission-Driven Quantum Application Development
Zapata Quantum (OTCQB: ZPTA) announced it has joined the IBM Quantum Network and will use IBM's quantum computers to accelerate quantum application development.
The move builds on prior joint IBM-Zapata research, including a quantum-enabled drug discovery study published in Nature Biotechnology that was named one of the journal's Top 10 Articles of 2025 for its work on KRAS inhibitor candidates.
Insights from the network membership will feed Zapata's hardware-agnostic Quantum Pilot platform; no financial terms were disclosed.